356
Participants
Start Date
February 1, 2024
Primary Completion Date
August 31, 2029
Study Completion Date
February 28, 2031
Focal therapy
"Focal therapy selectively treats a specific part of the prostate while preserving the rest of the gland in men with prostate cancer.~Focal therapy with ultrasound ablation (HIFU/TULSA) or irreversible electroporation (IRE) followed by an intensive MRI follow-up scheme at 12, 24, 36, 48 and 60 months, prostate biopsy at 12 months (and also when indicated) and PSA monitoring"
Usual care
standard radical treatment; prostatectomy or radiotherapy with follow-up according international guidelines (PSA monitoring and imaging when indicated).
RECRUITING
Radboud University Medical Centre, Nijmegen
NOT_YET_RECRUITING
Hifu kliniek, Etten-Leur
NOT_YET_RECRUITING
Amsterdam UMC, Amsterdam
NOT_YET_RECRUITING
Isala klinieken, Zwolle
NOT_YET_RECRUITING
St. Antonius hospital, Nieuwegein
Collaborators (1)
Isala
OTHER
Amsterdam UMC, location VUmc
OTHER
St. Antionius Hospital
UNKNOWN
Hifu kliniek
UNKNOWN
Dutch National Health Care Institute
OTHER
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Nederlandse Vereniging voor Radiotherapie en Oncologie
UNKNOWN
Wetenschapscommissie interventieradiologie/Nederlandse vereniging voor interventieradiologie
UNKNOWN
Inspire2live
UNKNOWN
Prostaatkankerstichting
UNKNOWN
Nederlandse Vereniging voor Urologie
UNKNOWN
Radboud University Medical Center
OTHER